Moleculin Biotech, Inc. Common Stock

MBRX US60855D2009

💰
Capitalization
Small-cap

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
7
🙍
Insiders
3
Person Price Shares Total Published Completed
Klemp Walter V
CEO
0.37
USD
675,675
Bought
250,000
USD
20/06/2025 23/06/2025
Klemp Walter V
CEO
0.37
USD
675,675
Bought
250,000
USD
20/06/2025 23/06/2025
Foster Jonathan P.
CFO
0.37
USD
270,270
Bought
100,000
USD
20/06/2025 23/06/2025
Foster Jonathan P.
CFO
0.37
USD
270,270
Bought
100,000
USD
20/06/2025 23/06/2025
Foster Jonathan P.
CFO
0.69
USD
28,986
Bought
20,000
USD
26/12/2023 26/12/2023
George Robert E.
0.69
USD
14,493
Bought
10,000
USD
26/12/2023 26/12/2023
Klemp Walter V
CEO
0.69
USD
188,404
Bought
129,999
USD
26/12/2023 26/12/2023
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Moleculin Biotech, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Klemp Walter V 3 629,998.26 209,999.42 26/12/2023 23/06/2025
Foster Jonathan P. 3 220,000.14 73,333.38 26/12/2023 23/06/2025
George Robert E. 1 10,000.17 10,000.17 26/12/2023 26/12/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.